Literature DB >> 14508172

Treatment of refractory fever in the neurosciences critical care unit using a novel, water-circulating cooling device. A single-center pilot experience.

J Ricardo Carhuapoma1, Kapil Gupta, William M Coplin, Salman M Muddassir, Muhammad M Meratee.   

Abstract

Fever after acute brain injury affects neuronal function and recovery. Standard therapies have proven to be inadequate in treating hyperthermia in this patient population. We report on safety/efficacy pilot data collected using a noninvasive, novel, water-circulating cooling device in febrile acute brain injury patients. We enrolled patients who developed fever (rectal temperature > or =38.0 degrees C) refractory to pharmacological therapy. The treatment device uses an ice water circulating system embedded in hydrogel-coated, energy transfer pads. Its thermoregulatory feedback control uses cold water (4.0 degrees C-42.0 degrees C) and was set at 36.5 degrees C for this study. We analyzed the temperature response during 600 consecutive minutes of treatment. Six consecutive patients were enrolled and seven episodes of fever were recorded; the mean age of the patients was 59.7 years (range 46-71 years; five male, one female). Diagnoses were as follows: subarachnoid hemorrhage (two), severe traumatic brain injury (two), status epilepticus following massive cerebral infarction (one), and intracerebral/intraventricular hemorrhage (one). Hand warming was applied at treatment onset on all patients; shivering only responsive to meperidine occurred in five of them. Fever of 38.4 degrees C (range 38.0 degrees C-38.9 degrees C) was reduced to 36.9 degrees C (range 36.0 degrees C-38.0 degrees C) after 120 minutes (P<0.001). Core temperature remained "locked" during the remainder of the treatment (36.6 degrees C, P=0.5; 36.6 degrees C, P=0.9; and 36.5 degrees C, P=0.9 at 180, 300, and 600 minutes, respectively). Skin integrity under the pads was preserved in all study subjects. Our results indicate that use of this novel technique is safe, rapidly effective, and able to maintain sustained normothermia following fever in a cohort of critically ill neurologic/neurosurgical patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14508172     DOI: 10.1097/00008506-200310000-00004

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  13 in total

Review 1.  Medivance Arctic sun temperature management system.

Authors:  Romergryko G Geocadin; J Ricardo Carhuapoma
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 2.  Fever management in SAH.

Authors:  V Scaravilli; G Tinchero; G Citerio
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 3.  Fever, hyperthermia, and the lung: it's all about context and timing.

Authors:  Jeffrey D Hasday; Nirav Shah; Phillip A Mackowiak; Mohan Tulapurkar; Ashish Nagarsekar; Ishwar Singh
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

4.  Nonpharmacologic approach to minimizing shivering during surface cooling: a proof of principle study.

Authors:  Nirav G Shah; Mark J Cowan; Edward Pickering; Houtan Sareh; Majid Afshar; Dawn Fox; Jennifer Marron; Jennifer Davis; Keith Herold; Carl B Shanholtz; Jeffrey D Hasday
Journal:  J Crit Care       Date:  2012-07-02       Impact factor: 3.425

Review 5.  Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.

Authors:  Michael N Diringer; Thomas P Bleck; J Claude Hemphill; David Menon; Lori Shutter; Paul Vespa; Nicolas Bruder; E Sander Connolly; Giuseppe Citerio; Daryl Gress; Daniel Hänggi; Brian L Hoh; Giuseppe Lanzino; Peter Le Roux; Alejandro Rabinstein; Erich Schmutzhard; Nino Stocchetti; Jose I Suarez; Miriam Treggiari; Ming-Yuan Tseng; Mervyn D I Vergouwen; Stefan Wolf; Gregory Zipfel
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 6.  Management of brain injury after resuscitation from cardiac arrest.

Authors:  Romergryko G Geocadin; Matthew A Koenig; Xiaofeng Jia; Robert D Stevens; Mary Ann Peberdy
Journal:  Neurol Clin       Date:  2008-05       Impact factor: 3.806

Review 7.  Clinical application of therapeutic hypothermia in stroke.

Authors:  Liping Liu; Midori A Yenari
Journal:  Neurol Res       Date:  2009-05       Impact factor: 2.448

8.  Predictors and clinical implications of shivering during therapeutic normothermia.

Authors:  Neeraj Badjatia; Robert G Kowalski; J Michael Schmidt; Marc E Voorhees; Jan Claassen; Noeleen D Ostapkovich; Mary Presciutti; E Sander Connolly; David Palestrant; Augusto Parra; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

9.  Modern treatment options for intracerebral hemorrhage.

Authors:  William D Freeman; Thomas G Brott
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.598

10.  Feasibility and Performance of a Gel-Adhesive Pad System for Pediatric Targeted Temperature Management: An Exploratory Analysis of 19 Pediatric Critically Ill Patients.

Authors:  Alicia M Alcamo; Rebecca Lavezoli; Cameron Dezfulian; Dennis W Simon; Rajesh K Aneja; Robert S B Clark; Patrick M Kochanek; Ericka L Fink
Journal:  Ther Hypothermia Temp Manag       Date:  2020-05-19       Impact factor: 1.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.